Brief: New Nordic Healthbrands Q4 EBITDA Turns To Loss Of SEK 4.0 Mln

New Nordic Healthbrands AB

28/02/2022 07:19

Feb 28 (Reuters) - New Nordic Healthbrands AB  NWND.ST :
    * FULL YEAR REPORT JANUARY - DECEMBER 2021
    * Q4 NET SALES SEK 121.0 MILLION VERSUS SEK 117.8 MILLION
YEAR AGO
    * Q4 EBITDA LOSS SEK 4.0 MILLION VERSUS PROFIT SEK 4.6MLN
YEAR AGO
    * OUTLOOK: CORONA RESTRICTIONS, GEOPOLITICAL CONCERNS AND
FINANCIAL CONCERNS HAVE CONTINUED INTO 2022.
    * OUTLOOK: IT IS CHALLENGING, BUT WE ARE CONVINCED THAT WE
WILL
PERFORM WELL IN 2022 WITH GROWTH IN BOTH SALES AND EARNINGS. I
CAN STATE THAT IN JANUARY 2022 WE HAD SATISFACTORY SALES AND
EARNINGS.
    * PREPARING TO APPLY FOR LISTING ON NASDAQ MAIN MARKET. OUR
PLAN
WAS TO APPLY IN 2021, BUT WE HAVE NOW DECIDED TO POSTPONE
APPLICATION UNTIL AUTUMN OF 2022.

Source text for Eikon:  ID:nBQN52Pbqr 
Further company coverage:  NWND.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))